Richman SD - Search Results

1

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.

Malla SB, Fisher DJ, Domingo E, Blake A, Hassanieh S, Redmond KL, Richman SD, Youdell M, Walker SM, Logan GE, Chatzipli A, Amirkhah R, Humphries MP, Craig SG, McDermott U, Seymour MT, Morton DG, Quirke P, West NP, Salto-Tellez M, Kennedy RD, Johnston PG, Tomlinson I, Koelzer VH, Campo L, Kaplan RS, Longley DB, Lawler M, Maughan TS, Brown LC, Dunne PD; S:CORT consortium. Malla SB, et al. Among authors: richman sd. Clin Cancer Res. 2021 Jan 1;27(1):288-300. doi: 10.1158/1078-0432.CCR-20-3237. Epub 2020 Oct 7. Clin Cancer Res. 2021. PMID: 33028592 Free PMC article.

2

Prediction of the response of colorectal cancer to systemic therapy.

Adlard JW, Richman SD, Seymour MT, Quirke P. Adlard JW, et al. Among authors: richman sd. Lancet Oncol. 2002 Feb;3(2):75-82. doi: 10.1016/s1470-2045(02)00648-4. Lancet Oncol. 2002. PMID: 11902527 Review.

3

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

Braun MS, Richman SD, Quirke P, Daly C, Adlard JW, Elliott F, Barrett JH, Selby P, Meade AM, Stephens RJ, Parmar MK, Seymour MT. Braun MS, et al. Among authors: richman sd. J Clin Oncol. 2008 Jun 1;26(16):2690-8. doi: 10.1200/JCO.2007.15.5580. J Clin Oncol. 2008. PMID: 18509181

4

MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.

Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, Scott K, Seymour M, Travis LB, Worrillow LJ, Bishop DT, Cox A; UK NCRI Colorectal Clinical Studies Group; Colorectal Cancer Study Group. Allan JM, et al. Int J Cancer. 2008 Nov 15;123(10):2456-9. doi: 10.1002/ijc.23770. Int J Cancer. 2008. PMID: 18712731

5

Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial.

Braun MS, Richman SD, Thompson L, Daly CL, Meade AM, Adlard JW, Allan JM, Parmar MK, Quirke P, Seymour MT. Braun MS, et al. Among authors: richman sd. J Clin Oncol. 2009 Nov 20;27(33):5519-28. doi: 10.1200/JCO.2008.21.6283. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858398 Clinical Trial.

6

KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial.

Richman SD, Seymour MT, Chambers P, Elliott F, Daly CL, Meade AM, Taylor G, Barrett JH, Quirke P. Richman SD, et al. J Clin Oncol. 2009 Dec 10;27(35):5931-7. doi: 10.1200/JCO.2009.22.4295. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884549 Clinical Trial.

7

What can the molecular pathologist offer for optimal decision making?

Richman SD, Hutchins GG, Seymour MT, Quirke P. Richman SD, et al. Ann Oncol. 2010 Oct;21 Suppl 7:vii123-9. doi: 10.1093/annonc/mdq379. Ann Oncol. 2010. PMID: 20943604 Free article. Review.

8

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

Hutchins G, Southward K, Handley K, Magill L, Beaumont C, Stahlschmidt J, Richman S, Chambers P, Seymour M, Kerr D, Gray R, Quirke P. Hutchins G, et al. J Clin Oncol. 2011 Apr 1;29(10):1261-70. doi: 10.1200/JCO.2010.30.1366. Epub 2011 Mar 7. J Clin Oncol. 2011. PMID: 21383284 Clinical Trial.

9

Failure to validate toxicity and outcome biomarkers from the FFCD 2000-05 trial in the MRC CR08 FOCUS trial.

Richman SD, Barrett JH, Seymour MT. Richman SD, et al. J Clin Oncol. 2011 Apr 20;29(12):e354-5; author reply e356-7. doi: 10.1200/JCO.2010.33.9556. Epub 2011 Mar 21. J Clin Oncol. 2011. PMID: 21422409 Free PMC article. No abstract available.

10

Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.

Richman SD, Chambers P, Seymour MT, Daly C, Grant S, Hemmings G, Quirke P. Richman SD, et al. Anal Cell Pathol (Amst). 2011;34(1-2):61-6. doi: 10.3233/ACP-2011-0005. Anal Cell Pathol (Amst). 2011. PMID: 21483104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters